课题基金 / 基金详情

Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study

Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study
通过共同创建对话代理来帮助人们坚持伐尼克兰治疗：可行性研究
批准号：
451438
负责人：
Minian Nadia
金额：
$20.34万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2024-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=451438&lang=en
关键词：
Conversational Agent Implementation Outcomes Medication Adherence Smoking Cessation

项目摘要

项目成果

Minian Nadia的其他基金

相似基金

相关文献

中文摘要
翻译
Varenicline是一种帮助人们戒烟的处方药。如果按处方服用，它是加拿大最有效的戒烟药物。然而，许多人并不坚持12周的养生法，而这一年
英文摘要
Varenicline is a prescription medication that helps people quit smoking tobacco. When taken as prescribed, it is the most effective smoking cessation medication available in Canada. However, many people do not adhere to the 12-week regimen, and this decre
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-creating digital solutions for problem drinking in treatment-seeking smokers to reduce (compounded) risk for cancer.
Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study
海外基金